CN101850054B - Chinese medicament for treating diabetic heart diseases - Google Patents
Chinese medicament for treating diabetic heart diseases Download PDFInfo
- Publication number
- CN101850054B CN101850054B CN2009102371024A CN200910237102A CN101850054B CN 101850054 B CN101850054 B CN 101850054B CN 2009102371024 A CN2009102371024 A CN 2009102371024A CN 200910237102 A CN200910237102 A CN 200910237102A CN 101850054 B CN101850054 B CN 101850054B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- diabetic heart
- sandalwood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
一种治疗糖尿病性心脏病的中药,属治疗心脑血管系统疾病的中药领域;目的是效果好,见效快;本发明采用檀香、生地、丹参、三七、灵芝、麦冬、当归等原料制成;它具有扶正培本,益气养血,滋阴清热,活血化瘀止痛的作用,具有效果显著,药效确切,见效较快的优点。This invention relates to a traditional Chinese medicine for treating diabetic heart disease, belonging to the field of traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases. The aim is to achieve good and rapid effects. This invention is made from raw materials such as sandalwood, rehmannia root, salvia miltiorrhiza, notoginseng, ganoderma lucidum, ophiopogon japonicus, and angelica sinensis. It has the effects of strengthening the body's resistance, replenishing qi and blood, nourishing yin and clearing heat, promoting blood circulation and relieving pain. It has the advantages of significant effects, definite efficacy, and rapid onset of action.
Description
技术领域technical field
本发明属于治疗心脑血管系统疾病的中药领域。The invention belongs to the field of traditional Chinese medicine for treating diseases of the cardiovascular and cerebrovascular systems.
背景技术Background technique
糖尿病性心脏病系糖尿病大血管病变和神经病变所致,是糖尿病最常见的并发症之一,也是糖尿病患者主要的致死原因。据统计,糖尿病患者70%死于糖尿病性心脏病。目前的旨在治疗糖尿病性心脏病方面存在两个方面的不足:一是效果不够明显,二是见效比较迟缓。以致于许多糖尿病性心脏病患者由于得不到有效药物的治疗,长期忍受胸闷胸痛、心悸不宁的折磨,面临心肌梗死的危险,患者及其家属对此不满意。Diabetic heart disease is caused by diabetic macroangiopathy and neuropathy. It is one of the most common complications of diabetes and the main cause of death in diabetic patients. According to statistics, 70% of diabetic patients died of diabetic heart disease. There are two deficiencies in the current method aimed at treating diabetic heart disease: one is that the effect is not obvious enough, and the other is that the effect is relatively slow. As a result, many diabetic heart disease patients suffer from chest tightness, chest pain, and palpitations for a long time due to lack of effective drug treatment, and face the danger of myocardial infarction. Patients and their families are not satisfied with this.
针对以上提出的问题,本发明提供一种治疗糖尿病性心脏病的中药,它能解决以往此类中药效果不够明显,见效比较迟缓的问题,效果好、见效快,具有效果显著,药效确切,见效较快的优点。In view of the problems raised above, the present invention provides a traditional Chinese medicine for the treatment of diabetic heart disease, which can solve the problem that the effect of such traditional Chinese medicines is not obvious enough in the past, and the effect is relatively slow. The advantage of quicker results.
发明内容Contents of the invention
本发明是通过以下技术方案来实现的:The present invention is achieved through the following technical solutions:
一种治疗糖尿病性心脏病的中药,采用中药原料制备,配方为(按重量比):A kind of Chinese medicine for treating diabetic heart disease is prepared by adopting Chinese medicine raw materials, and the formula is (by weight):
檀香3-20份 生地4-30份 丹参4-30份Sandalwood 3-20 parts Habitat 4-30 parts Salvia 4-30 parts
三七3-20份 灵芝2-12份 麦冬3-20份Panax notoginseng 3-20 parts Ganoderma lucidum 2-12 parts Ophiopogon japonicus 3-20 parts
当归3-20份Angelica 3-20 servings
这种治疗糖尿病性心脏病的中药是由下列方法制成的:This traditional Chinese medicine for treating diabetic heart disease is made by the following methods:
(1)按上述重量比,将檀香、生地、丹参、麦冬、当归经常规水提取工艺提取,制成浸膏细粉;(1) according to the above-mentioned weight ratio, sandalwood, raw land, salvia miltiorrhiza, Radix Ophiopogon japonicus, Angelica sinensis are extracted through conventional water extraction process, and extractum fine powder is made;
(2)按上述重量比,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Panax notoginseng and Ganoderma lucidum into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.
本发明是根据民间传统配方,根据中医扶正培本、活血化瘀的理论,精心研制而成。方中灵芝益气养血,养心安神,扶正培本,增强机体免疫力;生地黄性甘寒,长于滋阴清热,逐血痹而祛瘀;辅以麦冬养阴生津;三七、当归、丹参养血活血,化瘀止痛;佐以檀香行气温中,开胃止痛,常用于寒凝气滞,胸痛、腹痛、防治冠心病、心绞痛。诸药配伍,相得益彰,共奏扶正培本,益气养血,滋阴清热,活血化瘀止痛之功,效果好,见效快,具有效果显著,药效确切,见效较快的优点。The present invention is elaborately developed according to the folk traditional formula and the theory of traditional Chinese medicine of strengthening the body and strengthening the body, promoting blood circulation and removing blood stasis. In the prescription, Ganoderma lucidum nourishes qi and blood, nourishes the heart and calms the nerves, strengthens the body and strengthens the body, and enhances the body's immunity; Rehmannia glutinosa is sweet and cold in nature, good at nourishing yin and clearing away heat, clearing away blood stasis and blood stasis; supplemented with Ophiopogon japonicus to nourish yin and promote body fluid; Panax notoginseng, angelica, Salvia miltiorrhiza nourishes blood and activates blood, removes blood stasis and relieves pain; accompanied by sandalwood, warms the air, appetizers and relieves pain. It is often used for stagnation of Qi due to cold, chest pain, abdominal pain, and prevention and treatment of coronary heart disease and angina pectoris. All the medicines are compatible and complement each other. They play the functions of strengthening the body, nourishing qi and nourishing blood, nourishing yin and clearing heat, promoting blood circulation, removing blood stasis and relieving pain. The effect is good, and the effect is fast.
具体实施方式Detailed ways
通过以下实施方式对本发明做具体说明:The present invention is specifically described by the following embodiments:
1、取以下配方(重量按克为单位):1. Take the following formula (weight is in grams):
檀香60克 生地80克 丹参80克Sandalwood 60 grams Habitat 80 grams Salvia 80 grams
三七60克 灵芝40克 麦冬60克Panax notoginseng 60 grams Ganoderma lucidum 40 grams Ophiopogon japonicus 60 grams
当归60克Angelica 60g
按规定重量,用常规水提取工艺将檀香、生地、丹参、麦冬、当归提取,制成浸膏细粉102克,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀,制成细小颗粒,装入0号胶囊,制成中药胶囊721粒,每粒胶囊内含中药细粉及提取物0.28克。According to the specified weight, use the conventional water extraction process to extract sandalwood, raw land, salvia, radices, and angelica to make 102 grams of extract powder, grind Sanqi and Ganoderma lucidum into fine powders, and mix with the above extract fine powder , stir evenly, make fine particles, pack into No. 0 capsules, and make 721 Chinese medicine capsules, each capsule contains Chinese medicine fine powder and 0.28 grams of extract.
2、取以下配方(重量按克为单位):2. Take the following formula (weight is in grams):
檀香100克 生地150克 丹参150克Sandalwood 100g Rehmannia 150g Salvia miltiorrhiza 150g
三七100克 灵芝60克 麦冬100克Panax notoginseng 100g Ganoderma lucidum 60g Ophiopogon japonicus 100g
当归100克Angelica 100g
按上述同样的方法,制成中药胶囊1214粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 1214 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.
3、取以下配方(重量按克为单位):3. Take the following formula (the weight is in grams):
檀香200克 生地300克 丹参300克Sandalwood 200 grams Habitat 300 grams Salvia 300 grams
三七200克 灵芝120克 麦冬200克Panax notoginseng 200g Ganoderma lucidum 120g Ophiopogon japonicus 200g
当归200克Angelica 200g
按上述同样的方法,制成中药胶囊2428粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 2428 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.
4、取以下配方(按重量比):4. Take the following formula (by weight):
檀香5份 生地7份 丹参7份5 parts sandalwood 7 parts raw land 7 parts salvia
三七5份 灵芝3份 麦冬5份Panax notoginseng 5 servings Ganoderma lucidum 3 servings Ophiopogon japonicus 5 servings
当归5份Angelica 5 servings
按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, make Chinese medicine capsule, every capsule contains Chinese medicine fine powder and extract 0.28 gram.
5、取以下配方(按重量比):5. Take the following formula (by weight):
檀香15份 生地22份 丹参22份15 parts of sandalwood 22 parts of raw land 22 parts of salvia miltiorrhiza
三七15份 灵芝9份 麦冬15份Panax notoginseng 15 parts Ganoderma lucidum 9 parts Ophiopogon japonicus 15 parts
当归15份Angelica 15 servings
按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.
临床资料:clinical information:
本发明以中医糖尿病性心脏病为例,经8例临床观察。选择中医诊断糖尿病性心脏病为标准:糖尿病患者腰膝酸软,身体乏力;胸闷胸痛,心悸不宁;常有心动过速等心区不适。如上症状,即可确诊。在确诊观察的对象中,男性5例,女性3例,无其它严重疾病,年龄为48岁-78岁,平均年龄59.7岁。The present invention takes TCM diabetic heart disease as an example, through clinical observation of 8 cases. TCM diagnosis of diabetic heart disease was selected as the standard: diabetic patients have weak waist and knees, physical fatigue; chest tightness and pain, palpitations and restlessness; tachycardia and other heart discomfort. The above symptoms can be diagnosed. Among the confirmed observation objects, there were 5 males and 3 females, without other serious diseases, aged 48-78 years, with an average age of 59.7 years.
疗效判定:Judgment of curative effect:
1、显效:体质增强,身上有劲,胸闷胸痛、心悸不宁、心动过速等心区不适明显缓解,心电图可见心肌供血改善。1. Significant effect: Physical fitness is enhanced, body is strong, chest pain, palpitations, tachycardia and other heart discomfort are significantly relieved, and the electrocardiogram shows that the blood supply to the myocardium is improved.
2、有效:体质增强,胸闷胸痛等心区不适有所缓解。2. Effective: Physical fitness is enhanced, and discomfort in the heart area such as chest tightness and chest pain is relieved.
3、无效:病症无变化。3. Ineffective: no change in symptoms.
临床实验时,除糖尿病患者必须的降糖药照常服用(药不变、量不变)外,停服其它药物和保健营养品。服用本发明中药胶囊,观察3个月,为一个疗程。服用方法:每日3次,每次4粒胶囊,每粒胶囊内含中药细粉及提取物0.28克,饭后温开水送服,30天后症状即有缓解,服用3个月后,症状明显改善。临床实验的8人中,显效4人,有效3人,无效1人,总有效率87.5%。During clinical trials, except for the necessary hypoglycemic drugs for diabetic patients to take as usual (drugs and doses unchanged), other drugs and health nutrition products were stopped. Take Chinese medicine capsule of the present invention, observe 3 months, be a course of treatment. Dosing method: 3 times a day, 4 capsules each time, each capsule contains 0.28g of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 30 days, and the symptoms will be obvious after taking it for 3 months improve. Among the 8 people in the clinical trial, 4 people were markedly effective, 3 people were effective, and 1 person was ineffective, and the total effective rate was 87.5%.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102371024A CN101850054B (en) | 2009-11-04 | 2009-11-04 | Chinese medicament for treating diabetic heart diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102371024A CN101850054B (en) | 2009-11-04 | 2009-11-04 | Chinese medicament for treating diabetic heart diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101850054A CN101850054A (en) | 2010-10-06 |
| CN101850054B true CN101850054B (en) | 2011-07-20 |
Family
ID=42801844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102371024A Expired - Fee Related CN101850054B (en) | 2009-11-04 | 2009-11-04 | Chinese medicament for treating diabetic heart diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101850054B (en) |
-
2009
- 2009-11-04 CN CN2009102371024A patent/CN101850054B/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 陈建衡,等.中西医结合治疗糖尿病性心脏病34例.《中国中医药信息杂志》.2008,第15卷(第7期),60-61. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101850054A (en) | 2010-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843699B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843787B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843661B (en) | Chinese medicament for treating angina | |
| CN101843828A (en) | Chinese medicament for treating climacteric syndromes | |
| CN101843660B (en) | Chinese medicament for treating tachycardia | |
| CN101843690A (en) | Chinese medicament for treating osteoporosis | |
| CN101843712B (en) | Chinese medicament for treating angina | |
| CN101537121B (en) | Chinese medicine for treating arteriosclerosis | |
| CN101843717B (en) | Chinese medicament for treating coronary disease | |
| CN101843807A (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843831B (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101850015B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843877B (en) | Chinese medicament for treating liver cirrhosis | |
| CN101843753B (en) | Chinese medicament for treating angina | |
| CN101396468B (en) | A kind of traditional Chinese medicine for treating diabetic coronary heart disease | |
| CN101843793B (en) | Chinese medicament for treating tachycardia | |
| CN101849985B (en) | Chinese medicament for treating tachycardia | |
| CN101843645B (en) | Chinese medicament for treating tachycardia | |
| CN101843700A (en) | Chinese medicament for treating coronary disease | |
| CN101843720B (en) | Chinese medicament for treating angina | |
| CN101843805A (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843673B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101850054A (en) | A kind of traditional Chinese medicine for treating diabetic heart disease | |
| CN101843806B (en) | Chinese medicament for treating climacteric syndromes | |
| CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: LIU XINZHUANG Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20150722 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150722 Address after: 100040 Beijing city Shijingshan District double Jinyuan District 16 Building 2 unit 1102 Patentee after: Liu Xinzhuang Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110720 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |